Successful suppression of cataplectic attacks with tramadol

Neurology. 2003 Sep 23;61(6):864-5. doi: 10.1212/01.wnl.0000080367.25091.77.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Biogenic Monoamines / metabolism
  • Cataplexy / complications
  • Cataplexy / drug therapy*
  • Female
  • Humans
  • Middle Aged
  • Monoamine Oxidase Inhibitors / adverse effects
  • Monoamine Oxidase Inhibitors / therapeutic use
  • Morpholines / therapeutic use
  • Narcotics / pharmacology
  • Narcotics / therapeutic use*
  • Reboxetine
  • Receptors, Opioid / drug effects
  • Recurrence
  • Sleep, REM / drug effects
  • Substance Withdrawal Syndrome / etiology
  • Tramadol / pharmacology
  • Tramadol / therapeutic use*
  • Tranylcypromine / adverse effects
  • Tranylcypromine / therapeutic use
  • Treatment Outcome

Substances

  • Biogenic Monoamines
  • Monoamine Oxidase Inhibitors
  • Morpholines
  • Narcotics
  • Receptors, Opioid
  • Tramadol
  • Tranylcypromine
  • Reboxetine